We are seeking an experienced Programmer to join our dynamic Scientific Computing Team. You will develop and implement bioinformatics analysis pipelines for personalised medicine based on the Snakemake workflow management system to support the analysis of large volumes of deep sequencing and protein mass spectrometry data. Pipelines will run on a 2,000 core HPC Linux cluster that resides in a dedicated data centre. The Scientific Computing Team provides a stimulating and motivating work environment, you will be encouraged and supported to keep track in this field.
You will have excellent programming skills, a familiarity with workflow development and data management and strong communication skills. Experience with working in HPC environments and batch systems in particular is an advantage. This role is an exciting opportunity to join a highly interdisciplinary team that combines biology with computer science, mathematics and software engineering, whose goal is to help understanding the cancer genome.
Although an understanding of cancer genomics and cell biology would be advantageous, it is not a prerequisite.
enquiries please contact Dr Marek Dynowski, Head of Scientific Computing or Dr Crispin Miller, Head of the RNA Biology Group via email: firstname.lastname@example.org, email@example.com
The Cancer Research UK Manchester Institute (www.cruk.manchester.ac.uk), an Institute of The University of Manchester (www.manchester.ac.uk), is a world-leading centre for excellence in cancer research. The Institute is core funded by Cancer Research UK (www.cancerresearchuk.org), the largest independent cancer research organisation in the world. We are currently situated at the internationally-renowned life sciences campus at Alderley Park in Cheshire England, 15 miles from Manchester, a vibrant and dynamic city surrounded by beautiful countryside.
We are partnered with The Christie NHS Foundation Trust (adjacent to the CRUK MI Paterson Building) in South Manchester (www.christie.nhs.uk), one of the largest cancer treatment centres in Europe. These factors combine to provide an exceptional environment in which to pursue basic, translational and clinical research programmes.
Our aim is to understand the fundamental basis of cancer and apply that knowledge to developing new treatment strategies for cancer patients. Our advanced research programmes span a spectrum of cancer research, from the molecular and cellular basis of cancer through to drug discovery, translational research and clinical trials.
The Institute has outstanding laboratory facilities and exceptional core services, including next generation sequencing, microarrays, confocal microscopy, computational biology, histology and mass-spectrometry.
To apply for this position please visit our website: www.cruk.manchester.ac.uk